The research group aims to explore multiple aspects of malign and benign diseases of the esophagus and stomach.

For malignant disease this includes diagnostics, surgical techniques, morbidity, and survival. Perioperative oncologic therapy for malignant disease is also a focus for the multidisciplinary research group with several ongoing studies. A main coming research ambition is to explore histopathologic response to neoadjuvant therapy.

The group collaborates with researchers in translational studies including molecular and inflammatory aspects of malignant disease. A large biobank is available in collaboration with the Department of Molecular Oncology, Institute of Cancer Research. An early focus in this regard has been biomarkers aiming at early detection of cancer and biomarer monitoring effect of treatment and early discovery of recurrent disease.

Interventional and surgical aspects related to handeling of benign conditions like paraesophageal hernias, gastroesophageal reflux disease, myotomi for achalasia, esophageal diverticular disease, diafragmal hernias, and reconstructive surgery after previous gastroesophageal surgery, are also central research interests.